Bio-Techne (TECH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $72.52, +0.03% vs the prior close of $72.50.
- Volume 2.40M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TECH ends flat (+0.0%) to $72.52. Closed at $72.52, +0.03% vs the prior close of $72.50. Day range $72.50–$72.61, opened at $72.53.
TECH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TECH ends flat (+0.0%) to $72.52
- Closed at $72.52, +0.03% vs the prior close of $72.50. Day range $72.50–$72.61, opened at $72.53.
- Volume was 2.40M shares, 0.9x its 50-day average of 2.81M.
- Price is +0.2% vs its 50-day average ($72.37) and +15.7% vs its 200-day average ($62.67).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.2% below the 52-week high.
Oct 14, 2026 — TECH ends flat (+0.0%) to $72.50
- Closed at $72.50, +0.03% vs the prior close of $72.48. Day range $72.48–$72.54, opened at $72.50.
- Volume was 1.54M shares, 0.5x its 50-day average of 2.84M — lighter than usual.
- Price is +0.2% vs its 50-day average ($72.36) and +15.8% vs its 200-day average ($62.61).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 13, 2026 — TECH ends flat (-0.1%) to $72.48
- Closed at $72.48, -0.11% vs the prior close of $72.56. Day range $72.48–$72.55, opened at $72.49.
- Volume was 2.42M shares, 0.8x its 50-day average of 2.86M.
- Price is +0.2% vs its 50-day average ($72.35) and +15.9% vs its 200-day average ($62.54).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 12, 2026 — TECH ends flat (+0.1%) to $72.56
- Closed at $72.56, +0.14% vs the prior close of $72.46. Day range $72.44–$72.59, opened at $72.47.
- Volume was 2.42M shares, 0.8x its 50-day average of 2.89M.
- Price is +0.3% vs its 50-day average ($72.34) and +16.1% vs its 200-day average ($62.48).
- 52-week range $43.20–$72.69; today's close sits at 100% of that range, 0.2% below the 52-week high.
Oct 9, 2026 — TECH ends flat (+0.0%) to $72.46
- Closed at $72.46, +0.01% vs the prior close of $72.45. Day range $72.44–$72.52, opened at $72.46.
- Volume was 2.23M shares, 0.8x its 50-day average of 2.97M.
- Price is +0.2% vs its 50-day average ($72.33) and +16.1% vs its 200-day average ($62.41).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 8, 2026 — TECH ends flat (-0.1%) to $72.45 on 1.8x normal volume
- Closed at $72.45, -0.11% vs the prior close of $72.53. Day range $72.43–$72.58, opened at $72.56.
- Volume was 5.39M shares, 1.8x its 50-day average of 2.98M — unusually heavy trading.
- Price is +0.2% vs its 50-day average ($72.32) and +16.2% vs its 200-day average ($62.34).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 7, 2026 — TECH ends flat (+0.1%) to $72.53
- Closed at $72.53, +0.14% vs the prior close of $72.43. Day range $72.43–$72.55, opened at $72.43.
- Volume was 3.15M shares, 1.0x its 50-day average of 3.08M.
- Price is +0.3% vs its 50-day average ($72.32) and +16.5% vs its 200-day average ($62.27).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.2% below the 52-week high.
Oct 6, 2026 — TECH ends flat (-0.2%) to $72.43
- Closed at $72.43, -0.21% vs the prior close of $72.58. Day range $72.41–$72.61, opened at $72.58.
- Volume was 2.89M shares, 0.9x its 50-day average of 3.09M.
- Price is +0.2% vs its 50-day average ($72.31) and +16.5% vs its 200-day average ($62.19).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.4% below the 52-week high.
Oct 5, 2026 — TECH ends flat (+0.2%) to $72.58
- Closed at $72.58, +0.25% vs the prior close of $72.40. Day range $72.38–$72.61, opened at $72.41.
- Volume was 2.09M shares, 0.7x its 50-day average of 3.09M.
- Price is +0.4% vs its 50-day average ($72.29) and +16.8% vs its 200-day average ($62.12).
- 52-week range $43.20–$72.69; today's close sits at 100% of that range, 0.2% below the 52-week high.
Oct 2, 2026 — TECH ends flat (+0.0%) to $72.40
- Closed at $72.40, +0.00% vs the prior close of $72.40. Day range $72.38–$72.47, opened at $72.44.
- Volume was 1.87M shares, 0.6x its 50-day average of 3.12M — lighter than usual.
- Price is +0.2% vs its 50-day average ($72.27) and +16.7% vs its 200-day average ($62.04).
- 52-week range $43.20–$72.69; today's close sits at 99% of that range, 0.4% below the 52-week high.
TECH latest news & SEC filings
Every SEC filing by or about TECH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Higgins John L converted options/RSUs into 15,940 shares on Sep 28, 2026; now holds 82,816
- Higgins John L had withheld for taxes 5,562 shares at $72.51 (≈$403.30K) on Sep 28, 2026; now holds 77,254
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baumgartner Robert V converted options/RSUs into 15,940 shares on Sep 22, 2026; now holds 62,443
- Baumgartner Robert V had withheld for taxes 5,559 shares at $72.55 (≈$403.31K) on Sep 22, 2026; now holds 56,884
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 14, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Sep 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 9, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Sep 2, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Aug 25, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Aug 24, 2026 · 10-K — Annual report (audited full-year financial statements and business review)
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $1.22B (prior year $1.22B) (-0.4% vs Jun 30, 2025)
- Diluted EPS: $1.16 (prior year $0.46) (+152.2% vs Jun 30, 2025)
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade TECH
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.10% (largest 0.2%). That is a relatively calm stock.
- Liquidity: about 3.06M shares (≈$222.24M) trade per day on average.
- 52-week position: $72.52 vs a range of $43.20–$72.69 (99% of the range).
- Dividends: last ex-dividend date Aug 24, 2026 ($0.08/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 2 sales; latest: Amy E. Herr sold 6,636 shares on May 8, 2026.
- Latest filings: 8-K Sep 23, 2026; 8-K Sep 14, 2026; 10-K Aug 24, 2026.
- Share count: 156.82M shares outstanding (Aug 17, 2026), +0.8% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
TECH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 72.53 | 72.61 | 72.50 | 72.52 | 2.40M |
| Oct 14, 2026 | 72.50 | 72.54 | 72.48 | 72.50 | 1.54M |
| Oct 13, 2026 | 72.49 | 72.55 | 72.48 | 72.48 | 2.42M |
| Oct 12, 2026 | 72.47 | 72.59 | 72.44 | 72.56 | 2.42M |
| Oct 9, 2026 | 72.46 | 72.52 | 72.44 | 72.46 | 2.23M |
| Oct 8, 2026 | 72.56 | 72.58 | 72.43 | 72.45 | 5.39M |
| Oct 7, 2026 | 72.43 | 72.55 | 72.43 | 72.53 | 3.15M |
| Oct 6, 2026 | 72.58 | 72.61 | 72.41 | 72.43 | 2.89M |
| Oct 5, 2026 | 72.41 | 72.61 | 72.38 | 72.58 | 2.09M |
| Oct 2, 2026 | 72.44 | 72.47 | 72.38 | 72.40 | 1.87M |
| Oct 1, 2026 | 72.50 | 72.54 | 72.38 | 72.40 | 2.71M |
| Sep 30, 2026 | 72.38 | 72.55 | 72.33 | 72.47 | 3.14M |
| Sep 29, 2026 | 72.36 | 72.50 | 72.36 | 72.38 | 3.36M |
| Sep 28, 2026 | 72.58 | 72.65 | 72.49 | 72.51 | 3.82M |
| Sep 25, 2026 | 72.59 | 72.64 | 72.56 | 72.61 | 2.18M |
| Sep 24, 2026 | 72.54 | 72.63 | 72.51 | 72.57 | 2.99M |
| Sep 23, 2026 | 72.50 | 72.64 | 72.48 | 72.52 | 3.56M |
| Sep 22, 2026 | 72.52 | 72.69 | 72.46 | 72.55 | 3.44M |
| Sep 21, 2026 | 72.50 | 72.54 | 72.44 | 72.47 | 4.67M |
| Sep 18, 2026 | 72.41 | 72.44 | 72.26 | 72.37 | 5.02M |
About Bio-Techne
Bio-Techne (TECH) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MINNEAPOLIS, MN. State of incorporation: MN. Fiscal year ends June 30. SEC CIK 842023.
TECH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert V Baumgartner | Director | Sep 24, 2026 |
| Julie L Bushman | Director | Nov 3, 2025 |
| John L Higgins | Director | Sep 30, 2026 |
| Amy E. Herr | Director | Aug 19, 2026 |
| Joseph D Keegan | Director | Nov 3, 2025 |
| Kim Kelderman | Chief Executive Officer | Aug 19, 2026 |
| Judith V. Klimovsky | Director | Nov 3, 2025 |
| Alpna Seth | Director | Nov 3, 2025 |
| Rupert Vessey | Director | Nov 3, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Shane Bohnen | SVP - General Counsel | Aug 19, 2026 |
| Steven C. Crouse | President - Diag & Spatial Bi | Aug 19, 2026 |
| William Geist | PRESIDENT, PROTEIN SCIENCES | Aug 19, 2026 |
| James Hippel | CFO | Aug 19, 2026 |
| Kim Kelderman | Chief Executive Officer | Aug 19, 2026 |
| Matthew Mcmanus | President - Diag & Spatial Bio | Feb 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 8, 2026 | Amy E. Herr | Sale | 6,636 | $48.28 |
| Feb 17, 2026 | Amy E. Herr | Sale | 1,976 | $59.11 |
TECH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $1.22B | — | 1.16 | $292.07M |
| Jun 30, 2025 | $1.22B | $73.40M | 0.46 | $287.56M |
| Jun 30, 2024 | $1.16B | $168.10M | 1.05 | $298.98M |
| Jun 30, 2023 | $1.14B | $285.26M | 1.76 | $254.39M |
| Jun 30, 2022 | $1.11B | $272.05M | 1.66 | $325.27M |
Latest balance sheet: total assets $2.59B, total liabilities $—, cash $264.71M (as of Jun 30, 2026).
TECH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $72.23 |
| May 6, 2026 | 8-K Item 2.02 (results) | $47.41 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $68.67 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $59.94 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $49.87 |
| May 7, 2025 | 8-K Item 2.02 (results) | $48.75 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $75.25 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $76.02 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 1, 2024 | 8-K Item 2.02 (results) | — |
| Oct 31, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TECH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.